Wassenaar Arrangement Plenary Agreements Implementation: December 2007 Categories 1, 2, 3, 5 Parts I and II, 6, 7, and 9 of the Commerce Control List, Definitions; December 2006 Solar Cells, 65258 [Z8-23278]
Download as PDF
65258
Federal Register / Vol. 73, No. 213 / Monday, November 3, 2008 / Rules and Regulations
Paperwork Reduction Act
files such an application, the temporary
exemption expires on:
*
*
*
*
*
OTS has determined that this
extension does not involve a change to
collections of information previously
approved under the Paperwork
Reduction Act (44 U.S.C. 3501 et seq.).
Dated: October 29, 2008.
By the Office of Thrift Supervision.
John M. Reich,
Director.
[FR Doc. E8–26181 Filed 10–31–08; 8:45 am]
Unfunded Mandates Act of 1995
BILLING CODE 6720–01–P
impact on a substantial number of small
entities, as defined in the RFA.
For the reasons stated in the interim
final rule,4 OTS has determined that
this extension will not result in
expenditures by state, local, and tribal
governments, in the aggregate, or by the
private sector, of more than $100
million in any one year.
DEPARTMENT OF COMMERCE
Bureau of Industry and Security
15 CFR Parts 740, 772, and 774
[Docket No. 080215206-81243-01]
Executive Order 12866
OTS has determined that this
extension is not a significant regulatory
action under Executive Order 12866.
RIN 0694 AE29
Plain Language
Section 722 of the Gramm-LeachBliley Act (12 U.S.C. 4809) requires the
Agencies to use ‘‘plain language’’ in all
final rules published after January 1,
2000. OTS believes that the final rule
containing the extension is presented in
a clear and straightforward manner.
Wassenaar Arrangement Plenary
Agreements Implementation:
December 2007 Categories 1, 2, 3, 5
Parts I and II, 6, 7, and 9 of the
Commerce Control List, Definitions;
December 2006 Solar Cells
Correction
List of Subjects in 12 CFR Part 585
Administrative practice and
procedure, Holding companies,
Reporting and recordkeeping
requirements, Savings associations.
Authority and Issuance
For the reasons in the preamble, OTS
is amending part 585 of chapter V of
title 12 of the Code of Federal
Regulations as set forth below:
■
In rule document E8–23278 beginning
on page 60910 in the issue of October
14, 2008, make the following
corrections:
1. On page 60911, in the second
column, under the heading Revisions to
the Commerce Control List, in the 13th
and 14th lines, ‘‘1A006 and 1A007’’
should read ‘‘1A006, 1A007, and
3C006’’.
2. On the same page, in the same
column, under the same heading, in the
18th line, ‘‘3C005, 3C006, 3D001’’
should read ‘‘3C005, 3D001’’.
[FR Doc. Z8–23278 Filed 10–31–08; 8:45 am]
PART 585—PROHIBITED SERVICE AT
SAVINGS AND LOAN HOLDING
COMPANIES
BILLING CODE 1505–01–D
■
1. The authority citation for 12 CFR
part 585 continues to read as follows:
DEPARTMENT OF VETERANS
AFFAIRS
Authority: 12 U.S.C. 1462, 1462a, 1463,
1464, 1467a, and 1829(e).
38 CFR Part 1
2. In § 585.100, revise paragraph (b)(2)
introductory text to read as follows:
■
RIN 2900–AM65
*
erowe on PROD1PC64 with RULES
§ 585.100 Who is exempt from the
prohibition under this part?
Disclosure of Information to Organ,
Tissue and Eye Procurement
Organizations
AGENCY:
*
*
*
*
(b) * * *
(2) This exemption expires on March
31, 2009, unless the savings and loan
holding company or the person files an
application seeking a case-by-case
exemption for the person under
§ 585.110 by that date. If the savings and
loan holding company or the person
4 72
FR at 25954.
VerDate Aug<31>2005
15:09 Oct 31, 2008
Jkt 217001
ACTION:
Department of Veterans Affairs.
Final rule.
SUMMARY: This document adopts, with
changes, a Department of Veterans
Affairs (VA) interim final rule that
implemented provisions of the Veterans
Benefits, Health Care, and Information
Technology Act of 2006 concerning
disclosure of information to organ,
tissue and eye procurement
PO 00000
Frm 00018
Fmt 4700
Sfmt 4700
organizations. The regulation will
provide authority for VA to provide
individually-identifiable VA medical
records of veterans or dependents of
veterans who are deceased or whose
death is imminent to representatives of
organ procurement organizations, eye
banks, and tissue banks to determine
whether the patients are suitable
potential donors. This document
modifies the interim final rule to clarify
the definition of ‘‘near death’’ and to
correct a grammatical error in the
definition of ‘‘procurement
organization.’’ This document also
clarifies that eye bank and tissue bank
registration with FDA must have an
active status.
DATES: Effective Date: November 3,
2008.
FOR FURTHER INFORMATION CONTACT:
Stephania Putt, Veterans Health
Administration (VHA) Privacy Officer,
Office of Information (19F2), Veterans
Health Administration, Department of
Veterans Affairs, 810 Vermont Ave.,
NW., Washington, DC 20420, (704) 245–
2492.
SUPPLEMENTARY INFORMATION: On August
23, 2007, the Department of Veterans
Affairs (VA) published an interim final
rule in the Federal Register (72 FR
48239) to implement section 204 of
Public Law 109–461. We provided a 60day comment period which ended on
October 22, 2007. We received
comments from three organizations, the
American Association of Tissue Banks
(AATB), the Association of Organ
Procurement Organizations (AOPO),
and the Eye Bank Association of
America (EBAA).
AATB and EBAA commented on their
support of the provisions in the Interim
Final Rule in general. The support of the
AATB and EBAA is welcomed.
EBAA commented on the title of the
Interim Final Rule and suggested a title
of ‘‘Disclosure of Information to Organ,
Tissue and Eye Procurement
Organizations’’ to provide clarification.
The title of the Interim Final Rule is just
a title of the regulatory packet for
tracking and publication purposes; it is
not the title of the actual regulations.
We are amending the title of the Final
Rule to provide a clear understanding of
the organizations discussed in this
regulation.
AOPO commented that the definition
of ‘‘near death’’ used in the regulations
was vague and recommended the use of
clinical triggers in clearly defining near
or imminent death. We are amending
the definition of ‘‘near death’’ to include
the use of defined clinical triggers by
the health care provider when
E:\FR\FM\03NOR1.SGM
03NOR1
Agencies
[Federal Register Volume 73, Number 213 (Monday, November 3, 2008)]
[Rules and Regulations]
[Page 65258]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: Z8-23278]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF COMMERCE
Bureau of Industry and Security
15 CFR Parts 740, 772, and 774
[Docket No. 080215206[dash]81243[dash]01]
RIN 0694 AE29
Wassenaar Arrangement Plenary Agreements Implementation: December
2007 Categories 1, 2, 3, 5 Parts I and II, 6, 7, and 9 of the Commerce
Control List, Definitions; December 2006 Solar Cells
Correction
In rule document E8-23278 beginning on page 60910 in the issue of
October 14, 2008, make the following corrections:
1. On page 60911, in the second column, under the heading Revisions
to the Commerce Control List, in the 13th and 14th lines, ``1A006 and
1A007'' should read ``1A006, 1A007, and 3C006''.
2. On the same page, in the same column, under the same heading, in
the 18th line, ``3C005, 3C006, 3D001'' should read ``3C005, 3D001''.
[FR Doc. Z8-23278 Filed 10-31-08; 8:45 am]
BILLING CODE 1505-01-D